LEADER 02043nam  2200433   450 
001 9910717207303321
005 20221104181114.0
035   $a(CKB)4100000002891553
035   $a(NjHacI)994100000002891553
035   $a(OCoLC)1021274221
035   $a(EXLCZ)994100000002891553
100   $a20221104d2017      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aManagement of antiplatelet therapy among patients on antiplatelet therapy for coronary or cerebrovascular disease or with prior percutaneous cardiac interventions undergoing elective surgery $ea systematic review /$fPaul Shekelle [and seven others]
210  1$aWashington (DC) :$cDepartment of Veterans Affairs (US),$d[2017]
210  4$dİ2017
215   $a1 online resource (iii, 46 pages) $cillustrations
225 1 $aEvidence-based Synthesis Program
300   $a"June 2017."
320   $aIncludes bibliographical references.
410  0$aEvidence-based synthesis program (Series)
517   $aManagement of antiplatelet therapy among patients on antiplatelet therapy for coronary or cerebrovascular disease or with prior percutaneous cardiac interventions undergoing elective surgery
606   $aCoronary heart disease$xTreatment
615  0$aCoronary heart disease$xTreatment.
676   $a617.412
700   $aShekelle$b Paul G.$01236354
712 02$aUnited States.$bDepartment of Veterans Affairs.$bHealth Services Research and Development Service,
712 02$aQuality Enhancement Research Initiative (U.S.)
712 02$aWest Los Angeles VA Medical Center.$bEvidence-Based Synthesis Program Center.
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910717207303321
996   $aManagement of antiplatelet therapy among patients on antiplatelet therapy for coronary or cerebrovascular disease or with prior percutaneous cardiac interventions undergoing elective surgery$93295950
997   $aUNINA